These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 15981957)
41. Influence of activated charcoal on the pharmacokinetics and the clinical features of carbamazepine poisoning. Brahmi N; Kouraichi N; Thabet H; Amamou M Am J Emerg Med; 2006 Jul; 24(4):440-3. PubMed ID: 16787802 [TBL] [Abstract][Full Text] [Related]
42. Teicoplanin population pharmacokinetic analysis in hospitalized patients. Soy D; López E; Ribas J Ther Drug Monit; 2006 Dec; 28(6):737-43. PubMed ID: 17164688 [TBL] [Abstract][Full Text] [Related]
43. Population pharmacokinetic investigation of actinomycin-D in children and young adults. Mondick JT; Gibiansky L; Gastonguay MR; Skolnik JM; Cole M; Veal GJ; Boddy AV; Adamson PC; Barrett JS J Clin Pharmacol; 2008 Jan; 48(1):35-42. PubMed ID: 18094218 [TBL] [Abstract][Full Text] [Related]
44. Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults. Menon-Andersen D; Mondick JT; Jayaraman B; Thompson PA; Blaney SM; Bernstein M; Bond M; Champagne M; Fossler MJ; Barrett JS Cancer Chemother Pharmacol; 2009 Jan; 63(2):229-38. PubMed ID: 18398615 [TBL] [Abstract][Full Text] [Related]
45. Population pharmacokinetics of motexafin gadolinium in adults with brain metastases or glioblastoma multiforme. Miles DR; Smith JA; Phan SC; Hutcheson SJ; Renschler MF; Ford JM; Boswell GW J Clin Pharmacol; 2005 Mar; 45(3):299-312. PubMed ID: 15703365 [TBL] [Abstract][Full Text] [Related]
46. Pregnancy-related effects on nelfinavir-M8 pharmacokinetics: a population study with 133 women. Hirt D; Treluyer JM; Jullien V; Firtion G; Chappuy H; Rey E; Pons G; Mandelbrot L; Urien S Antimicrob Agents Chemother; 2006 Jun; 50(6):2079-86. PubMed ID: 16723569 [TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetic and pharmacodynamic modeling of a copper-selective chelator (TETA) in healthy adults. Cho HY; Blum RA; Sunderland T; Cooper GJ; Jusko WJ J Clin Pharmacol; 2009 Aug; 49(8):916-28. PubMed ID: 19602718 [TBL] [Abstract][Full Text] [Related]
48. Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomiting. Nakade S; Ohno T; Kitagawa J; Hashimoto Y; Katayama M; Awata H; Kodama Y; Miyata Y Cancer Chemother Pharmacol; 2008 Dec; 63(1):75-83. PubMed ID: 18317761 [TBL] [Abstract][Full Text] [Related]
49. Population pharmacokinetics of infliximab in patients with ankylosing spondylitis. Xu Z; Seitz K; Fasanmade A; Ford J; Williamson P; Xu W; Davis HM; Zhou H J Clin Pharmacol; 2008 Jun; 48(6):681-95. PubMed ID: 18401017 [TBL] [Abstract][Full Text] [Related]
50. Steady state pharmacokinetics of conventional versus controlled-release carbamazepine in patients with epilepsy. Bonneton J; Iliadis A; Genton P; Dravet C; Viallat D; Mesdjian E Epilepsy Res; 1993 Mar; 14(3):257-63. PubMed ID: 8504796 [TBL] [Abstract][Full Text] [Related]
51. Patterns of care, outcomes, and direct health plan costs of antiepileptic therapy: a pharmacoeconomic analysis of the available carbamazepine formulations. Garnett WR; Gilbert TD; O'Connor P Clin Ther; 2005 Jul; 27(7):1092-103. PubMed ID: 16154489 [TBL] [Abstract][Full Text] [Related]
52. Laser evoked potentials and carbamazepine in epileptic patients. Galeotti F; Truini A; Iannetti GD; Romaniello A; Biasiotta A; Mascia A; Virtuoso M; Cruccu G Neurophysiol Clin; 2005 Jul; 35(2-3):93-6. PubMed ID: 16087072 [TBL] [Abstract][Full Text] [Related]
53. Population pharmacokinetics of carbamazepine in elderly patients. Punyawudho B; Ramsay ER; Brundage RC; Macias FM; Collins JF; Birnbaum AK Ther Drug Monit; 2012 Apr; 34(2):176-81. PubMed ID: 22406657 [TBL] [Abstract][Full Text] [Related]
54. Iron supplements in nursing home patients associated with reduced carbamazepine absorption. Ahn JE; Bathena SPR; Brundage RC; Conway JM; Leppik IE; Birnbaum AK Epilepsy Res; 2018 Nov; 147():115-118. PubMed ID: 30327119 [TBL] [Abstract][Full Text] [Related]
55. CYP1A2 genotype affects carbamazepine pharmacokinetics in children with epilepsy. Djordjevic N; Milovanovic DD; Radovanovic M; Radosavljevic I; Obradovic S; Jakovljevic M; Milovanovic D; Milovanovic JR; Jankovic S Eur J Clin Pharmacol; 2016 Apr; 72(4):439-45. PubMed ID: 26762380 [TBL] [Abstract][Full Text] [Related]
56. Pharmacokinetic profile of flunarizine after single and multiple dosing in epileptic patients receiving comedication. Kapetanovic IM; Torchin CD; Kupferberg HJ; Treiman DM; Di Giorgio C; Barber K; Norton L; Lau M; Whitley L; Cereghino JJ Epilepsia; 1988; 29(6):770-4. PubMed ID: 3191893 [TBL] [Abstract][Full Text] [Related]
57. Kinetic profile of carbamazepine in an adult Portuguese outpatient population. Almeida AM; Falcão AC; Sales F; Leitão F; Santos J; Costa IM; Caramona MM J Clin Pharm Ther; 1998 Aug; 23(4):315-21. PubMed ID: 9867316 [TBL] [Abstract][Full Text] [Related]
58. Pharmacoepidemiologic investigation of a clonazepam-carbamazepine interaction by mixed effect modeling using routine clinical pharmacokinetic data in Japanese patients. Yukawa E; Nonaka T; Yukawa M; Ohdo S; Higuchi S; Kuroda T; Goto Y J Clin Psychopharmacol; 2001 Dec; 21(6):588-93. PubMed ID: 11763006 [TBL] [Abstract][Full Text] [Related]
59. Evaluation of clinical and genetic factors in the population pharmacokinetics of carbamazepine. Yip VLM; Pertinez H; Meng X; Maggs JL; Carr DF; Park BK; Marson AG; Pirmohamed M Br J Clin Pharmacol; 2021 Jun; 87(6):2572-2588. PubMed ID: 33217013 [TBL] [Abstract][Full Text] [Related]
60. [Clinical pharmacokinetics of carbamazepine (review of the literature)]. Martynova LA; Puzin MN; Seleznev AN Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(10):145-8. PubMed ID: 2694702 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]